Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.
Brain Commun
; 4(6): fcac309, 2022.
Article
in En
| MEDLINE
| ID: mdl-36523269
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Brain Commun
Year:
2022
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido